Notice of Cipher Pharmaceuticals Q3 2018 Conference Call

MISSISSAUGA, ON, Oct. 24, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced the details of its Q3 2018 financial results conference call on Wednesday, November 7, 2018. The call will be hosted by Robert Tessarolo, President and Chief Executive Officer, and Stephen Lemieux, Chief Financial Officer. The Company will issue its financial results on the morning of November 7, 2018. 

CONFERENCE CALL DETAILS

DATE:	Wednesday, November 7, 2018
TIME:	8:30 a.m. EST
DIAL IN NUMBER:	[phone] or [phone]
CONFERENCE ID:	34175672
REPLAY:	[phone] or [phone] (playback code 175672) Available until midnight (EST) November 14, 2018
WEBCAST:	The audio webcast can be accessed at http://cipher.investorroom.com/ under Investor Relations or at https://event.on24.com/wcc/r/1865375/ECD67237F8B0A2DCCC17B86659CF5B78

About Cipher Pharmaceuticals Inc.
Cipher (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. Cipher is focused on a three-pronged growth strategy – including acquisitions, in-licensing, and selective investments in drug development – to assemble a broad portfolio of prescription products that serve unmet medical needs. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Stefan Eftychiou, [email protected], [phone] ext. 60

Related Links

http://www.cipherpharma.com